Clinical characteristics of autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy in children: A case series of 16 patients

J Neuroimmunol. 2023 Sep 15:382:578176. doi: 10.1016/j.jneuroim.2023.578176. Epub 2023 Aug 7.

Abstract

Purpose: To investigate the clinical characteristics of autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy in children.

Methods: We reviewed the medical records of Children's Hospital of Chongqing Medical University from January 2020 to September 2021 and retrospectively analysed the clinical features, magnetic resonance imaging (MRI) findings, laboratory findings, treatment and outcome of children with autoimmune GFAP astrocytopathy.

Results: Sixteen patients were included: 6 and 10 tested positive for GFAP-IgG in cerebrospinal fluid (CSF) and both CSF and serum, respectively. The median patient age was 115 months (range: 36-180 months), and 7 patients (43.8%) were male. All patients had the clinical syndrome of encephalitis/meningoencephalitis with or without myelitis: encephalitis (8), meningoencephalitis (3), encephalomyelitis (1) and meningoencephalomyelitis (4). The most common clinical symptoms were fever (11), altered consciousness (11), headache (10) and seizure (9). Four patients developed central respiratory failure for which mechanical ventilation was needed. All patients showed hyperintense T2-weighted lesions on brain MRI in the cerebral white matter (13), brainstem (11), basal ganglia (11), thalamus (9), and cerebellum (3). Nine patients (56%) had abnormal hyperintense lesions in the bilateral basal ganglia and thalamus. Six of 12 patients who underwent gadolinium-enhanced brain MRI showed abnormal enhancement images, and five of them showed linear perivascular radial enhancement. The modified Rankin scale (mRS) score decreased significantly in most patients after immunotherapy. Two patients with coexisting neural autoantibodies relapsed; however, 15 patients who were followed up successfully had favorable outcomes at the last follow-up.

Conclusion: Children with autoimmune GFAP astrocytopathy usually have a clinical syndrome of encephalitis/meningoencephalitis with or without myelitis. Except for the linear perivascular radial gadolinium enhancement pattern, hyperintense lesions in the bilateral basal ganglia and thalamus might be another characteristic brain MRI finding of autoimmune GFAP astrocytopathy in children. Although a few patients with coexisting neural autoantibodies might relapse, children with autoimmune GFAP astrocytopathy usually have favorable outcomes after immunotherapy.

Keywords: Autoimmune encephalitis; Children; Encephalitis; GFAP-IgG; Glial fibrillary acidic protein.

Publication types

  • Review

MeSH terms

  • Adolescent
  • Astrocytes* / metabolism
  • Astrocytes* / pathology
  • Autoantibodies
  • Autoimmune Diseases of the Nervous System* / diagnostic imaging
  • Autoimmune Diseases of the Nervous System* / genetics
  • Autoimmune Diseases of the Nervous System* / metabolism
  • Child
  • Child, Preschool
  • Contrast Media
  • Encephalitis* / complications
  • Encephalitis* / diagnostic imaging
  • Encephalitis* / therapy
  • Encephalomyelitis* / diagnostic imaging
  • Encephalomyelitis* / therapy
  • Female
  • Gadolinium
  • Glial Fibrillary Acidic Protein
  • Humans
  • Male
  • Meningoencephalitis* / diagnostic imaging
  • Myelitis*
  • Retrospective Studies

Substances

  • Autoantibodies
  • Contrast Media
  • Gadolinium
  • Glial Fibrillary Acidic Protein
  • GFAP protein, human